Understanding your diagnosis. Dr Graham Collins Consultant Haemtologist Oxford University Hospitals

Size: px
Start display at page:

Download "Understanding your diagnosis. Dr Graham Collins Consultant Haemtologist Oxford University Hospitals"

Transcription

1 Understanding your diagnosis Dr Graham Collins Consultant Haemtologist Oxford University Hospitals

2 Common questions I get asked What is lymphoma? What subtype do I have and what does that mean? What are the symptoms of lymphoma? What causes lymphoma (why me.?) How common is lymphoma? What stage of lymphoma do I have? How is lymphoma treated? What is my life expectancy? What new treatments are coming through?

3 What is lymphoma? Good question!

4 What is lymphoma? It s not at all obvious.. Breast cancer cancer of the breast! Colon cancer cancer of the colon!

5 So what is lymphoma? Is it a cancer? Yes! What is it a cancer of? The lymphatic system

6 What is my subtype?

7 What are the different types of lymphoma? Lymphoma: cancer of lymphocytes Hodgkin Lymphoma Non-Hodgkin Lymphoma Classical Hodgkin Lymphoma Nodular Lymphocyte Predominant Hodgkin Lymphoma T-cell NHL B-cell NHL High Grade Low grade Diffuse Large B-cell CLL Burkitt Follicular Lymphoblastic Marginal zone

8 Low grade NHL Slowly progressive Increases with age - never seen in children Without treatment, may live for many years Treatment variable: aingle agent chemo, multiagent chemo, antibodies, radiotherapy Follicular lymphoma Marginal zone lymphoma Lymphoplasmacytic lymphoma Usually no cause some exceptions e.g. gastric MALT Generally NOT considered curable with chemotherapy

9 High grade NHL Rapidly progressive Increases with age but do see in children Without treatment, survival only months Treated with combination chemotherapy (+ monoclonal antibodies) Diffuse large B- cell lymphoma Burkitt Lymphoma Lymphoblastic lymphoma Usually no cause - HIV is a risk factor Fequently curable with chemotherapy

10 Why are there so many different types? Naïve B-cell Transitional B-cell Follicular B-cell Spleen Marginal zone B- cell Memory B-cell Lymph node Stem cell Germinal centre Mantle zone Antigen presentation Bone marrow Plasma cell

11 How do we tell what subtype it is? A biopsy is vital to get the right diagnosis There are 2 main types of biopsy: 1. Excision biopsy (the node is taken out under a quick general anaesthetic) 2. Core biopsy (a thin apple-core is taken out under local anaesthetic using an ultrasound or CT maching to guide the needle).

12 Pathologists a key part of the team

13 What a pathologist sees Follicular lymphoma Classical Hodgkin lymphoma Diffuse large B-cell lymphoma Special antibody-based stains and sometimes genetic tests are used to confirm the diagnosis

14 What are the symptoms of lymphoma?

15 Usually symptoms are due to a lump Neck lump I felt it when I was shaving Chest lump I can t stop coughing when I lie flat Brain lump I got lost on my way home from work

16 Other symptoms Almost anything B symptoms : fever, weight loss, drenching night sweats Fatigue (tiredness) Itch Alcohol induced pain Rash

17 What causes lymphoma?

18 What causes lymphoma? For most cases we just don t know Factors which increase the risk: Reduced immune system (e.g. after a transplant) Infections: HIV, Helicobacter pylori, EBV Inflammatory diseases (e.g. sjogren syndrome, thyroiditis) Certain medications (e.g. methotrexate) POSSIBLY certain toxins e.g. pesticides

19 How common is lymphoma?

20 How common is lymphoma? Approx 16,000 new cases each year

21 Who gets lymphoma? Non-Hodgkin Increases with age Hodgkin Commonest in young

22 Is it getting more common? Yes! And we don t know why

23 What stage do I have?

24 Staging is with a PET or CT

25 Staging by PET Stage I Stage II Stage III Stage IV

26 How is lymphoma treated?

27 It depends. Not everyone needs treatment: watch and wait is standard management for low grade lymphoma without symptoms Hodgkin and high grade lymphoma nearly always needs treatment: chemotherapy + antibody therapy +/- radiotherapy Low grade lymphoma treatment is more variable: more gentle chemotherapy (one or more drugs); nearly always antibody treatment Stem cell transplants are needed for some relapsed lymphomas (and rarely as first line treatment)

28 Chemotherapy Unlike many other cancer, chemotherapy is very effective in lymphoma and has saved many thousands of lives All thanks to chemical weapons!

29 Antibody treatment (rituximab) Complement proteins Effector T-cells Direct cell kill

30 What is my life expectancy?

31 Survival with lymphoma is improving!

32 Example: follicular lymphoma

33 What new treatments are coming through?

34 A lot of new treatments are being tested! 1. New (and hopefully improved) antibodies 2. Antibodies with chemotherapy on the end 3. Antibodies with radiotherapy on the end 4. Drugs which target molecules which lymphoma cells need to stay alive 5. Immune system cells which are engineered to attack lymphoma cells

35 Summary Lymphoma is a cancer of the lymphatic system It is complicated because lymphocytes have a complicated life cycle Hodgkin and non-hodgkin is the broadest division It is the 5 th commonest cancer It affects young and old It is getting more common (and not just because we re all getting older!) For most people we cannot identify a cause Survival with lymphoma is improving When it s needed, treatment is with chemotherapy and antibody therapy (sometimes radiotherapy) Lots of new treatment are being tested in trials

36 Thank you for listening

Lymphatic system component

Lymphatic system component Introduction Lymphatic system component Statistics Overview Lymphoma Non Hodgkin s Lymphoma Non- Hodgkin's is a type of cancer that originates in the lymphatic system. It is estimated to be the sixth most

More information

Lymphoma is a cancer that develops in the white blood cells (lymphocytes) of the lymphatic system, which is part of the body's immune system.

Lymphoma is a cancer that develops in the white blood cells (lymphocytes) of the lymphatic system, which is part of the body's immune system. Scan for mobile link. Lymphoma Lymphoma is a cancer that develops in the white blood cells of the lymphatic system. Symptoms may include enlarged lymph nodes, unexplained weight loss, fatigue, night sweats

More information

Lymphoma: The Basics. Dr. Douglas Stewart

Lymphoma: The Basics. Dr. Douglas Stewart Lymphoma: The Basics Dr. Douglas Stewart Objectives What is lymphoma? How common is it? Why does it occur? How do you diagnose it? How do you manage it? How do you follow patients after treatment? What

More information

Non-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL)

Non-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL) Non-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL) Lymphoid Neoplasms: 1- non-hodgkin lymphomas (NHLs) 2- Hodgkin lymphoma 3- plasma cell neoplasms Non-Hodgkin lymphomas (NHLs) Acute Lymphoblastic Leukemia/Lymphoma

More information

LYMPHOMA Joginder Singh, MD Medical Oncologist, Mercy Cancer Center

LYMPHOMA Joginder Singh, MD Medical Oncologist, Mercy Cancer Center LYMPHOMA Joginder Singh, MD Medical Oncologist, Mercy Cancer Center Lymphoma is cancer of the lymphatic system. The lymphatic system is made up of organs all over the body that make up and store cells

More information

Large cell immunoblastic Diffuse histiocytic (DHL) Lymphoblastic lymphoma Diffuse lymphoblastic Small non cleaved cell Burkitt s Non- Burkitt s

Large cell immunoblastic Diffuse histiocytic (DHL) Lymphoblastic lymphoma Diffuse lymphoblastic Small non cleaved cell Burkitt s Non- Burkitt s Non Hodgkin s Lymphoma Introduction 6th most common cause of cancer death in United States. Increasing in incidence and mortality. Since 1970, the incidence of has almost doubled. Overview The types of

More information

Indolent Lymphomas. Dr. Melissa Toupin The Ottawa Hospital

Indolent Lymphomas. Dr. Melissa Toupin The Ottawa Hospital Indolent Lymphomas Dr. Melissa Toupin The Ottawa Hospital What does indolent mean? Slow growth Often asymptomatic Chronic disease with periods of relapse (long natural history possible) Incurable with

More information

Hodgkin's Lymphoma. Symptoms. Types

Hodgkin's Lymphoma. Symptoms. Types Hodgkin's lymphoma (Hodgkin's disease) usually develops in the lymphatic system, a part of the body's immune system. This system carries disease-fighting white blood cells throughout the body. Lymph tissue

More information

Lymphoma: What You Need to Know. Richard van der Jagt MD, FRCPC

Lymphoma: What You Need to Know. Richard van der Jagt MD, FRCPC Lymphoma: What You Need to Know Richard van der Jagt MD, FRCPC Overview Concepts, classification, biology Epidemiology Clinical presentation Diagnosis Staging Three important types of lymphoma Conceptualizing

More information

Lymphoma/CLL 101: Know your Subtype. Dr. David Macdonald Hematologist, The Ottawa Hospital

Lymphoma/CLL 101: Know your Subtype. Dr. David Macdonald Hematologist, The Ottawa Hospital Lymphoma/CLL 101: Know your Subtype Dr. David Macdonald Hematologist, The Ottawa Hospital Function of the Lymph System Lymph Node Lymphocytes B-cells develop in the bone marrow and influence the immune

More information

Lymphoma: What You Need to Know

Lymphoma: What You Need to Know Lymphoma: What You Need to Know www.lymphoma.org.au Lymphoma What You Need to Know Whilst Lymphoma Australia (LA) has made every effort to confirm the accuracy of the information contained herein, it makes

More information

Low-grade non-hodgkin lymphoma

Low-grade non-hodgkin lymphoma Low-grade non-hodgkin lymphoma Low-grade non-hodgkin lymphoma small lymphocytic lymphoma nodal marginal zone CLL Waldenström s macroglobulinaemia marginal zone gastric MALT chronic lymphocytic leukaemia

More information

Lymphoma 101. Nathalie Johnson, MDPhD. Division of Hematology Jewish General Hospital Associate Professor of Medicine, McGill University

Lymphoma 101. Nathalie Johnson, MDPhD. Division of Hematology Jewish General Hospital Associate Professor of Medicine, McGill University Lymphoma 101 Nathalie Johnson, MDPhD Division of Hematology Jewish General Hospital Associate Professor of Medicine, McGill University Disclosures Consultant and Advisory boards for multiple companies

More information

NON- HODGKIN LYMPHOMA

NON- HODGKIN LYMPHOMA NON- HODGKIN LYMPHOMA non - Hodgkin lymphoma This medical guide is designed for educational purposes to help patients understand. Please consult your doctor on specific questions and details about your

More information

Lymphoma Read with the experts

Lymphoma Read with the experts Lymphoma Read with the experts Marc Seltzer, MD Associate Professor of Radiology Geisel School of Medicine at Dartmouth Director, PET-CT Course American College of Radiology Learning Objectives Recognize

More information

Low-grade non-hodgkin lymphoma

Low-grade non-hodgkin lymphoma Low-grade non-hodgkin lymphoma Low-grade non-hodgkin lymphoma Follicular lymphoma Chronic lymphocytic leukaemia Small lymphocytic lymphoma Mantle cell lymphoma Marginal zone lymphomas Cutaneous (skin)

More information

2012 by American Society of Hematology

2012 by American Society of Hematology 2012 by American Society of Hematology Common Types of HIV-Associated Lymphomas DLBCL includes primary CNS lymphoma (PCNSL) Burkitt Lymphoma HIV-positive patients have a 60-200 fold increased incidence

More information

7 Omar Abu Reesh. Dr. Ahmad Mansour Dr. Ahmad Mansour

7 Omar Abu Reesh. Dr. Ahmad Mansour Dr. Ahmad Mansour 7 Omar Abu Reesh Dr. Ahmad Mansour Dr. Ahmad Mansour -Leukemia: neoplastic leukocytes circulating in the peripheral bloodstream. -Lymphoma: a neoplastic process in the lymph nodes, spleen or other lymphatic

More information

Pathology #07. Hussein Al-Sa di. Dr. Sohaib Al-Khatib. Mature B-Cell Neoplasm. 0 P a g e

Pathology #07. Hussein Al-Sa di. Dr. Sohaib Al-Khatib. Mature B-Cell Neoplasm. 0 P a g e Pathology #07 Mature B-Cell Neoplasm Hussein Al-Sa di Dr. Sohaib Al-Khatib 0 P a g e Thursday 18/2/2016 Our lecture today (with the next 2 lectures) will be about lymphoid tumors This is a little bit long

More information

Aggressive Lymphomas - Current. Dr Kevin Imrie Physician-in-Chief, Sunnybrook Health Sciences Centre

Aggressive Lymphomas - Current. Dr Kevin Imrie Physician-in-Chief, Sunnybrook Health Sciences Centre Aggressive Lymphomas - Current Dr Kevin Imrie Physician-in-Chief, Sunnybrook Health Sciences Centre Conflicts of interest I have no conflicts of interest to declare Outline What does aggressive lymphoma

More information

Lymphoma and Myeloma Kris3ne Kra4s, M.D.

Lymphoma and Myeloma Kris3ne Kra4s, M.D. Lymphoma and Myeloma Kris3ne Kra4s, M.D. Hematologic Malignancies Leukemia Malignancy of hematopoie3c cells Starts in bone marrow, can spread to blood, nodes Myeloid or lymphoid Acute or chronic Lymphoma

More information

Overview of Cutaneous Lymphomas: Diagnosis and Staging. Lauren C. Pinter-Brown MD, FACP Health Sciences Professor of Medicine and Dermatology

Overview of Cutaneous Lymphomas: Diagnosis and Staging. Lauren C. Pinter-Brown MD, FACP Health Sciences Professor of Medicine and Dermatology Overview of Cutaneous Lymphomas: Diagnosis and Staging Lauren C. Pinter-Brown MD, FACP Health Sciences Professor of Medicine and Dermatology Definition of Lymphoma A cancer or malignancy that comes from

More information

Monsanto s Spin on its Roundup herbicide is Unwinding

Monsanto s Spin on its Roundup herbicide is Unwinding Monsanto s Spin on its Roundup herbicide is Unwinding By: Thomas T. Dunbar, Esq. Recently, information about the potential danger posed by Monsanto s Roundup has surfaced as a result of information discovered

More information

Aggressive NHL and Hodgkin Lymphoma. Dr. Carolyn Faught November 10, 2017

Aggressive NHL and Hodgkin Lymphoma. Dr. Carolyn Faught November 10, 2017 Aggressive NHL and Hodgkin Lymphoma Dr. Carolyn Faught November 10, 2017 What does aggressive mean? Shorter duration of symptoms Generally need treatment at time of diagnosis Immediate, few days, few weeks

More information

Indolent Lymphomas: Current. Dr. Laurie Sehn

Indolent Lymphomas: Current. Dr. Laurie Sehn Indolent Lymphomas: Current Dr. Laurie Sehn Why does indolent mean? Slow growth Often asymptomatic Chronic disease with periods of relapse (long natural history possible) Incurable with current standard

More information

Information. about cancer

Information. about cancer 1 Information about cancer This chapter may help you answer simple questions about what cancer is and how it is treated. There are more than 200 different types of cancer and a range of treatments. Being

More information

Non-Hodgkin lymphoma

Non-Hodgkin lymphoma Non-Hodgkin lymphoma Non-Hodgkin s lymphoma Definition: - clonal tumours of mature and immature B cells, T cells or NK cells - highly heterogeneous, both histologically and clinically Non-Hodgkin lymphoma

More information

1. Please review the following table, make any changes you think are necessary and highlight those changes. Feel free to put notes on the next page

1. Please review the following table, make any changes you think are necessary and highlight those changes. Feel free to put notes on the next page COME HOME Non-Hodgkin pathway development worksheet, v6 September 2014 1. Please review the following table, make any changes you think are necessary and highlight those changes. Feel free to put notes

More information

Page 1 of 9 Title Authored By Course No Contact Hours 2 ABCs of Lymphoma Anita Rothera RNC, BS, CDE LYM020108 Purpose The goal of this course is to help health care professionals learn about the different

More information

SURVIVORSHIP WITH LYMPHOMA APRIL SHAMY MD,CM JEWISH GENERAL HOSPITAL MCGILL UNIVERSITY

SURVIVORSHIP WITH LYMPHOMA APRIL SHAMY MD,CM JEWISH GENERAL HOSPITAL MCGILL UNIVERSITY SURVIVORSHIP WITH LYMPHOMA APRIL SHAMY MD,CM JEWISH GENERAL HOSPITAL MCGILL UNIVERSITY Some Statistics Approximately 1 in 2 Canadians develop cancer 25% of Canadians die of cancer 2009: 810,000 Canadians

More information

Blood Cancer: Chronic Myelogenous Leukaemia

Blood Cancer: Chronic Myelogenous Leukaemia Published on: 30 May 2017 Blood Cancer: Chronic Myelogenous Leukaemia What Is Cancer? The body is made up of cells that grow and die in a controlled way. Sometimes, cells keep dividing and growing without

More information

Clinical Commissioning Policy Proposition: Bendamustine with rituximab for relapsed indolent non-hodgkin s lymphoma (all ages)

Clinical Commissioning Policy Proposition: Bendamustine with rituximab for relapsed indolent non-hodgkin s lymphoma (all ages) Clinical Commissioning Policy Proposition: Bendamustine with rituximab for relapsed indolent non-hodgkin s lymphoma (all ages) Reference: NHS England 1607 1 First published: TBC Prepared by NHS England

More information

CLINICAL MEDICAL POLICY

CLINICAL MEDICAL POLICY CLINICAL MEDICAL POLICY Policy Name: Rituxan (rituximab) Policy Number: MP-031-MD-DE Responsible Department(s): Medical Management; Clinical Pharmacy Provider Notice Date: 10/01/2017 Issue Date: 11/01/2017

More information

B. Misunderstanding about clinical trials as an effective option to treatment; and

B. Misunderstanding about clinical trials as an effective option to treatment; and ANALYSIS I. INTRODUCTION In early 2012, the Lymphoma Coalition launched an on-line global survey to its 54 member organizations and their local members to help them gain a better understanding of and determine

More information

BLOOD AND LYMPH CANCERS

BLOOD AND LYMPH CANCERS BLOOD AND LYMPH CANCERS 2 Blood and Lymph Cancers Highlights from the 2009 Annual Meeting of the American Society of Clinical Oncology Edited by Kenneth C. Anderson, MD Harvard Medical School and Dana-Farber

More information

CHRONIC LYMPHOCYTIC LEUKEMIA

CHRONIC LYMPHOCYTIC LEUKEMIA CHRONIC LYMPHOCYTIC LEUKEMIA This medical guide is designed for educational purposes to help patients understand. Please consult your doctor on specific questions and details about your symptoms. 02 03

More information

Molecular Pathology of Lymphoma (Part 1) Rex K.H. Au-Yeung Department of Pathology, HKU

Molecular Pathology of Lymphoma (Part 1) Rex K.H. Au-Yeung Department of Pathology, HKU Molecular Pathology of Lymphoma (Part 1) Rex K.H. Au-Yeung Department of Pathology, HKU Lecture outline Time 10:00 11:00 11:15 12:10 12:20 13:15 Content Introduction to lymphoma Review of lymphocyte biology

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest

More information

Hosts. Advances in the Treatment of Lymphomas. Guest Expert: Daniel Persky, MD Assistant Professor of Medicine (Hematology), Yale School of Medicine

Hosts. Advances in the Treatment of Lymphomas. Guest Expert: Daniel Persky, MD Assistant Professor of Medicine (Hematology), Yale School of Medicine Hosts Anees MD Associate Professor of Surgical Oncology Francine Foss MD Professor of Medical Oncology Advances in the Treatment of Lymphomas Guest Expert: Daniel, MD Assistant Professor of Medicine (Hematology),

More information

7.342 Chronic infection and inflammation: What are the consequences on your health? Instructors Eva Frickel and Sara Gredmark

7.342 Chronic infection and inflammation: What are the consequences on your health? Instructors Eva Frickel and Sara Gredmark 7.342 Chronic infection and inflammation: What are the consequences on your health? Instructors Eva Frickel and Sara Gredmark How to read a scientific paper Organization of a paper - Title - Authors and

More information

Understanding Lymphoma

Understanding Lymphoma Understanding Lymphoma Guest Expert: Francine, MD Professor of Medicine www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers with Drs. Ed and Francine, I am Bruce Barber. Dr. is

More information

Early diagnosis saves lives #SpotLeukaemia

Early diagnosis saves lives #SpotLeukaemia Early diagnosis saves lives #SpotLeukaemia Leukaemia... is a blood cancer affects people of all ages Leukaemia symptoms are hard to spot, as they are similar to the symptoms of common, unrelated conditions.

More information

Lymphoma John P. Leonard, M.D.

Lymphoma John P. Leonard, M.D. Lymphoma 2017 John P. Leonard, M.D. Richard T. Silver Distinguished Professor of Hematology and Medical Oncology Associate Dean for Clinical Research Vice Chairman, Department of Medicine Disclosures Consulting

More information

NON HODGKINS LYMPHOMA: INDOLENT Updated June 2015 by Dr. Manna (PGY-5 Medical Oncology Resident, University of Calgary)

NON HODGKINS LYMPHOMA: INDOLENT Updated June 2015 by Dr. Manna (PGY-5 Medical Oncology Resident, University of Calgary) NON HODGKINS LYMPHOMA: INDOLENT Updated June 2015 by Dr. Manna (PGY-5 Medical Oncology Resident, University of Calgary) Reviewed by Dr. Michelle Geddes (Staff Hematologist, University of Calgary) and Dr.

More information

Update in Lymphoma Imaging

Update in Lymphoma Imaging Update in Lymphoma Imaging Victorine V. Muse, MD Lymphoma Update in Lymphoma Imaging Victorine V Muse, MD Heterogeneous group of lymphoid neoplasms divided into two broad histological categories Hodgkin

More information

A CASE OF PRIMARY THYROID LYMPHOMA. Prof Dr.Dilek Gogas Yavuz Marmara University School of Medicine Endocrinology and Metabolism Istanbul, Turkey

A CASE OF PRIMARY THYROID LYMPHOMA. Prof Dr.Dilek Gogas Yavuz Marmara University School of Medicine Endocrinology and Metabolism Istanbul, Turkey A CASE OF PRIMARY THYROID LYMPHOMA Prof Dr.Dilek Gogas Yavuz Marmara University School of Medicine Endocrinology and Metabolism Istanbul, Turkey 38 year old female She recognized a mass in her right neck

More information

High-grade non-hodgkin lymphoma (NHL)

High-grade non-hodgkin lymphoma (NHL) High-grade non-hodgkin lymphoma (NHL) Introduction 1 A guide to DLBCL and other fast-growing non-hodgkin lymphomas For anyone affected by blood cancer bloodwise.org.uk Patient information As the weeks

More information

Lymphocyte Predominant Hodgkin s Lymphoma. Case Presentation. How would you treat the patient?

Lymphocyte Predominant Hodgkin s Lymphoma. Case Presentation. How would you treat the patient? Lymphocyte Predominant Hodgkin s Lymphoma Wei Ai, MD, PhD Assistant Clinical Professor University of California, San Francisco January 2010 Case Presentation 32 yo male, diagnosed with stage IIIA lymphocyte

More information

FINALIZED SEER SINQ S NOVEMBER 2011

FINALIZED SEER SINQ S NOVEMBER 2011 : 20110133 Multiple primaries/heme & Lymphoid Neoplasms: A patient was diagnosed 7/31/08 with DLBCL (9680/3) (biopsy left supraclav. node), stage IIIB. Treated with chemo. 10/14/10 biopsy right supraclav.

More information

Blood Cancers. Blood Cells. Blood Cancers: Progress and Promise. Bone Marrow and Blood. Lymph Nodes and Spleen

Blood Cancers. Blood Cells. Blood Cancers: Progress and Promise. Bone Marrow and Blood. Lymph Nodes and Spleen Blood Cancers: Progress and Promise Mike Barnett & Khaled Ramadan Division of Hematology Department of Medicine Providence Health Care & UBC Blood Cancers Significant health problem Arise from normal cells

More information

Approach to Core Biopsy Specimens

Approach to Core Biopsy Specimens BDIAP 108th Symposium on Haematopathology Joint Meeting of the BDIAP and BLPG at-bristol, Anchor Road, Harbourside, Bristol BS1 5DB 15th - 17th May 2014 Approach to Core Biopsy Specimens Dr Stefan Dojcinov

More information

Dr. Noelle O Rourke Beatson Oncology Centre, Glasgow RADIOTHERAPY FOR LYMPHOMA???

Dr. Noelle O Rourke Beatson Oncology Centre, Glasgow RADIOTHERAPY FOR LYMPHOMA??? Dr. Noelle O Rourke Beatson Oncology Centre, Glasgow RADIOTHERAPY FOR LYMPHOMA??? History of Radiotherapy 1895 Rontgen describes X-rays 1896 Becquerel radioactivity 1905 Radiation is used to treat tumours

More information

VI.2 Elements for a public summary

VI.2 Elements for a public summary VI.2 Elements for a public summary VI.2.1 Overview of disease epidemiology Leukaemia is a cancer that starts in the blood-forming cells of the bone marrow. Chronic lymphocytic leukaemia (CLL) is a type

More information

GAZYVA for Chronic Lymphocytic Leukemia (CLL)

GAZYVA for Chronic Lymphocytic Leukemia (CLL) GAZYVA for Chronic Lymphocytic Leukemia (CLL) GAZYVA is a prescription medicine used with the chemotherapy drug, chlorambucil, to treat chronic lymphocytic leukemia (CLL) in adults who have not had previous

More information

Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia (CLL) Page 1 of 10 PATIENT EDUCATION Chronic Lymphocytic Leukemia (CLL) Introduction Chronic lymphocytic leukemia (CLL) is a type of cancer of the lymphocytes (a kind of white blood cell). It is also referred

More information

Opdivo (nivolumab) An overview of Opdivo and why it is authorised in the EU. What is Opdivo and what is it used for?

Opdivo (nivolumab) An overview of Opdivo and why it is authorised in the EU. What is Opdivo and what is it used for? EMA/852560/2018 EMEA/H/C/003985 An overview of Opdivo and why it is authorised in the EU What is Opdivo and what is it used for? Opdivo is a cancer medicine used to treat the following: melanoma, a type

More information

Oncology 101. Cancer Basics

Oncology 101. Cancer Basics Oncology 101 Cancer Basics What Will You Learn? What is Cancer and How Does It Develop? Cancer Diagnosis and Staging Cancer Treatment What is Cancer? Cancer is a group of more than 100 different diseases

More information

APPLICATION FOR SUBSIDY BY SPECIAL AUTHORITY

APPLICATION FOR SUBSIDY BY SPECIAL AUTHORITY Page 1 Rituximab INITIAL APPLICATION - Post-transplant The patient has B-cell post-transplant lymphoproliferative disder* To be used f a maximum of 8 treatment cycles Indications marked with * are Unapproved

More information

Non-Hodgkin Lymphoma in Clinically Difficult Situations

Non-Hodgkin Lymphoma in Clinically Difficult Situations Winship Cancer Institute of Emory University Non-Hodgkin Lymphoma in Clinically Difficult Situations James Armitage, MD Professor, Department of Internal Medicine Joe Shapiro Distinguished Chair of Oncology

More information

Hodgkin Disease Early Detection, Diagnosis, and Staging

Hodgkin Disease Early Detection, Diagnosis, and Staging Hodgkin Disease Early Detection, Diagnosis, and Staging Detection and Diagnosis Catching cancer early often allows for more treatment options. Some early cancers may have signs and symptoms that can be

More information

LYMPHOMA DIAGNOSIS and PROGNOSIS. LC Lim Dept of Hematology Singapore General Hospital

LYMPHOMA DIAGNOSIS and PROGNOSIS. LC Lim Dept of Hematology Singapore General Hospital LYMPHOMA DIAGNOSIS and PROGNOSIS LC Lim Dept of Hematology Singapore General Hospital OUTLINE Accurate diagnosis Define subtype : WHO classification Staging : Defines extent of involvement Prognosis Determining

More information

HAEMATOLOGICAL MALIGNANCY

HAEMATOLOGICAL MALIGNANCY HAEMATOLOGICAL MALIGNANCY Reference Compulsory reading Haematology at Glance 2 nd ed. Atul Mehta & Victor Hoffbrand Chapters: 20 to 31 Pages: 46 to 69 Pathogenesis of Haematological Malignancy Figure (a)

More information

Instructions for Chronic Lymphocytic Leukemia Post-HSCT Data (Form 2113)

Instructions for Chronic Lymphocytic Leukemia Post-HSCT Data (Form 2113) Instructions for Chronic Lymphocytic Leukemia Post-HSCT Data (Form 2113) This section of the CIBMTR Forms Instruction Manual is intended to be a resource for completing the CLL Post-HSCT Data Form. E-mail

More information

Blood Cancers in the Community

Blood Cancers in the Community Over to you, mate Blood Cancers in the Community National Rural Health Conference NZ Rural General Practice Network April 7, 2018 Brian Grainger Haematology Registrar Auckland Acknowledgements Dr James

More information

The Lymphoma Guide Information for Patients and Caregivers

The Lymphoma Guide Information for Patients and Caregivers The Lymphoma Guide Information for Patients and Caregivers Ashton, lymphoma survivor This publication was supported by Revised 2016 Publication Update The Lymphoma Guide: Information for Patients and Caregivers

More information

High-grade non-hodgkin lymphoma

High-grade non-hodgkin lymphoma High-grade non-hodgkin lymphoma High-grade non-hodgkin lymphoma Diffuse large B-cell lymphoma Other large B-cell lymphomas Burkitt lymphoma Mantle cell lymphoma Central nervous system lymphoma T-cell lymphomas

More information

Hodgkin lymphoma. Hodgkin lymphoma edition

Hodgkin lymphoma. Hodgkin lymphoma edition Hodgkin lymphoma Hodgkin lymphoma 2016 edition When I was diagnosed I took things as they came and was actually glad that they d found the root of my problems. At least it meant I could start getting better.

More information

Diagnosis and patient pathway in lymphomas

Diagnosis and patient pathway in lymphomas The Royal Marsden Diagnosis and patient pathway in lymphomas Dr Ian Chau Consultant Medical Oncologist The Royal Marsden Hospital London & Surrey Change Presentation title and date in Footer dd.mm.yyyy

More information

Hodgkin lymphoma. Hodgkin lymphoma. Understanding lymphoma. Diagnosis and staging. Treatment. Side effects. Looking after yourself

Hodgkin lymphoma. Hodgkin lymphoma. Understanding lymphoma. Diagnosis and staging. Treatment. Side effects. Looking after yourself Hodgkin lymphoma Hodgkin lymphoma Understanding lymphoma Diagnosis and staging Treatment Side effects Looking after yourself About this book This booklet tells you what Hodgkin lymphoma is, and how it

More information

A 64yo female with tuberculous empyema not improving on treatment: A tribute and farewell to Dr. Alphonse Kayembe

A 64yo female with tuberculous empyema not improving on treatment: A tribute and farewell to Dr. Alphonse Kayembe A 64yo female with tuberculous empyema not improving on treatment: A tribute and farewell to Dr. Alphonse Kayembe Continuing Medical Education Announcement Harvard Medical School RSS 3081: Monthly BOTSOGO

More information

LEUKAEMIA and LYMPHOMA. Dr Mubarak Abdelrahman Assistant Professor Jazan University

LEUKAEMIA and LYMPHOMA. Dr Mubarak Abdelrahman Assistant Professor Jazan University LEUKAEMIA and LYMPHOMA Dr Mubarak Abdelrahman Assistant Professor Jazan University OBJECTIVES Identify etiology and epidemiology for leukemia and lymphoma. Discuss common types of leukemia. Distinguish

More information

Neoplasms/Lymphoma/Leukemia

Neoplasms/Lymphoma/Leukemia Neoplasms/Lymphoma/Leukemia Session Guidelines This is a 15 minute webinar session for CNC physicians and staff CNC holds webinars monthly to address topics related to risk adjustment documentation and

More information

LYMPHOMAS an overview of some subtypes of NHLs

LYMPHOMAS an overview of some subtypes of NHLs One of the confusing aspects of the lymphoid neoplasms concerns the use of the descriptive terms "leukemia" and "lymphoma." LYMPHOMAS an overview of some subtypes of NHLs Leukemia is used for lymphoid

More information

KTE-C19 for relapsed or refractory mantle cell lymphoma

KTE-C19 for relapsed or refractory mantle cell lymphoma NIHR Innovation Observatory Evidence Briefing: July 2017 KTE-C19 for relapsed or refractory mantle cell lymphoma NIHRIO (HSRIC) ID: 11846 NICE ID: 9122 LAY SUMMARY Mantle cell lymphoma is an uncommon type

More information

Leukemia And Lymphoma In The Nervous System

Leukemia And Lymphoma In The Nervous System Leukemia And Lymphoma In The Nervous System If you are searching for the book Leukemia and Lymphoma in the Nervous System in pdf format, then you've come to the right site. We presented complete variant

More information

A Guide for Patients and Caregivers

A Guide for Patients and Caregivers DLBCL Starting KYMRIAH A Guide for Patients and Caregivers APPROVED USE WHAT IS KYMRIAH? KYMRIAH (tisagenlecleucel) is made from your own white blood cells and is a prescription cancer treatment used in

More information

The Lymphomas. An overview..

The Lymphomas. An overview.. The Lymphomas An overview.. Peter Anglin MD, FRCPC, MBA Stronach Regional Cancer Centre Newmarket, ON The lymphomas are an important part of the history of medicine 1666 Magpighi publishes first recorded

More information

Cancer , The Patient Education Institute, Inc. ocf80101 Last reviewed: 06/08/2016 1

Cancer , The Patient Education Institute, Inc.   ocf80101 Last reviewed: 06/08/2016 1 Cancer Introduction Cancer begins in your cells, which are the building blocks of your body. Extra cells can form a mass called a tumor. Some tumors aren t cancerous, while other ones are. Cells from cancerous

More information

Harmesh Naik, MD. GME Presentation to Family Practice Residents October 16, 2013.

Harmesh Naik, MD. GME Presentation to Family Practice Residents October 16, 2013. Harmesh Naik, MD. GME Presentation to Family Practice Residents October 16, 2013. Lymphoma: Lympho-proliferative disorders arising from lymphocytes Heterogeneous group of disorders Differing patterns of

More information

Immunopathology of Lymphoma

Immunopathology of Lymphoma Immunopathology of Lymphoma Noraidah Masir MBBCh, M.Med (Pathology), D.Phil. Department of Pathology Faculty of Medicine Universiti Kebangsaan Malaysia Lymphoma classification has been challenging to pathologists.

More information

HODGKIN DISEASE. What is cancer?

HODGKIN DISEASE. What is cancer? HODGKIN DISEASE What is cancer? Cancer develops when cells in a part of the body begin to grow out of control. Although there are many kinds of cancer, they all start because of out-of-control growth of

More information

Lymphatic System Disorders

Lymphatic System Disorders Lymphatic System Disorders Lymphomas Malignant neoplasms involving lymphocyte proliferation in lymph nodes Specific causes not identified // Higher risk in adults who received radiation during childhood

More information

Patient underwent hemicolectomy: 7 x 4.5 cm intusscepted segment of ileum in colon - mucosal

Patient underwent hemicolectomy: 7 x 4.5 cm intusscepted segment of ileum in colon - mucosal Extranodal Lymphomas Rena Buckstein Odette Cancer Center Case: JT 69 yo male COO software company PMHx: basal cell back, cholesterol Presents to ER with severe abdominal pain, bloody diarrhea x 2d In ER

More information

Roche s subcutaneous formulation of MabThera approved in Switzerland for the treatment of common types of non-hodgkin lymphoma

Roche s subcutaneous formulation of MabThera approved in Switzerland for the treatment of common types of non-hodgkin lymphoma Media Release Basel, 12 January 2017 Roche s subcutaneous formulation of MabThera approved in Switzerland for the treatment of common types of non-hodgkin lymphoma Administration time significantly reduced

More information

Non-Hodgkin Lymphoma Early Detection, Diagnosis, and Staging

Non-Hodgkin Lymphoma Early Detection, Diagnosis, and Staging Non-Hodgkin Lymphoma Early Detection, Diagnosis, and Staging Detection and Diagnosis Catching cancer early often allows for more treatment options. Some early cancers may have signs and symptoms that can

More information

Indium-111 Zevalin Imaging

Indium-111 Zevalin Imaging Indium-111 Zevalin Imaging Background: Most B lymphocytes (beyond the stem cell stage) contain a surface antigen called CD20. It is possible to kill these lymphocytes by injecting an antibody to CD20.

More information

2018 KSMO Immune Oncology Forum. Immune checkpoint inhibitors in hematologic. malignancies: evidences and perspectives 서울아산병원종양내과 홍정용

2018 KSMO Immune Oncology Forum. Immune checkpoint inhibitors in hematologic. malignancies: evidences and perspectives 서울아산병원종양내과 홍정용 2018 KSMO Immune Oncology Forum Immune checkpoint inhibitors in hematologic malignancies: evidences and perspectives 서울아산병원종양내과 홍정용 2018-07-18 Contents Introduction Immune checkpoint inhibtors in lymphomas

More information

GAZYVA: for follicular lymphoma that has not responded to or has returned after treatment

GAZYVA: for follicular lymphoma that has not responded to or has returned after treatment GAZYVA: for follicular lymphoma that has not responded to or has returned after treatment GAZYVA is a prescription medicine used with the chemotherapy drug, bendamustine, followed by GAZYVA alone for follicular

More information

Notification to Implement Issued by pcodr: December 14, 2012

Notification to Implement Issued by pcodr: December 14, 2012 PROVINCIAL FUNDING SUMMARY Bendamustine hydrochloride (Treanda) for indolent Non-Hodgkin Lymphoma and Mantle Cell Lymphoma (first-line and relapsed/refractory) perc Recommendation: Recommends For further

More information

Hodgkin lymphoma (HL)

Hodgkin lymphoma (HL) Hodgkin lymphoma (HL) Introduction 1 For anyone affected by blood cancer bloodwise.org.uk Patient information As the weeks passed and having gathered copious quantities of information from charities, books

More information

REPORT ON PROSPECTIVE AUDIT OF LYMPHOMA PATIENTS BORDERS, FIFE, AND LOTHIAN DIAGNOSED IN 2008

REPORT ON PROSPECTIVE AUDIT OF LYMPHOMA PATIENTS BORDERS, FIFE, AND LOTHIAN DIAGNOSED IN 2008 SE Scotland Cancer Network SCAN AUDIT REPORT ON PROSPECTIVE AUDIT OF LYMPHOMA PATIENTS BORDERS, FIFE, AND LOTHIAN DIAGNOSED IN 2008 Reports prepared by: Christine Maguire SCAN Cancer Audit Facilitator

More information

CLL: A Guide for Patients and Caregivers CHRONIC LYMPHOCYTIC LEUKEMIA

CLL: A Guide for Patients and Caregivers CHRONIC LYMPHOCYTIC LEUKEMIA CLL: A Guide for Patients and Caregivers LEUKEMIA LYMPHOMA CHRONIC LYMPHOCYTIC LEUKEMIA MYELOMA Introduction In the U.S. In 2006, about 91,000 people were living with CLL In 2007, more than 15,000 people

More information

News from ASH: Updates on Lymphoma and Other Blood Cancers ASH Conference Coverage December 8, 2008 Andrew Evens, D.O.

News from ASH: Updates on Lymphoma and Other Blood Cancers ASH Conference Coverage December 8, 2008 Andrew Evens, D.O. News from ASH: Updates on Lymphoma and Other Blood Cancers ASH Conference Coverage December 8, 2008 Andrew Evens, D.O. Please remember the opinions expressed on Patient Power are not necessarily the views

More information

NICE guideline Published: 20 July 2016 nice.org.uk/guidance/ng52

NICE guideline Published: 20 July 2016 nice.org.uk/guidance/ng52 Non-Hodgkin s lymphoma: diagnosis and management NICE guideline Published: 20 July 2016 nice.org.uk/guidance/ng52 NICE 2017. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

Medcenter One Cancer Committee 2011 Annual Report

Medcenter One Cancer Committee 2011 Annual Report Medcenter One Cancer Committee 211 Annual Report With a Focus on Non-Hodgkin s Lymphoma 21 CND Cancer Registry Statistics Medcenter One Health Systems is proud to be recognized as an accredited cancer

More information

Lymphomas and multiple myeloma 12/23/2018 1

Lymphomas and multiple myeloma 12/23/2018 1 60 Lymphomas and multiple myeloma 12/23/2018 1 Lymphomas Lymphoma is cancer of the lymphatic system. Lymphomas are subdivided into two main categories: Hodgkin's lymphoma (HL) and non- Hodgkin's lymphoma

More information

What is a hematological malignancy? Hematology and Hematologic Malignancies. Etiology of hematological malignancies. Leukemias

What is a hematological malignancy? Hematology and Hematologic Malignancies. Etiology of hematological malignancies. Leukemias Hematology and Hematologic Malignancies Cancer of the formed elements of the blood What is a hematological malignancy? A hematologic malignancy is a malignancy (or cancer) of any of the formed elements

More information

Acute Lymphocytic Leukemia Early Detection, Diagnosis, and Types

Acute Lymphocytic Leukemia Early Detection, Diagnosis, and Types Acute Lymphocytic Leukemia Early Detection, Diagnosis, and Types Detection and Diagnosis Catching cancer early often allows for more treatment options. Some early cancers may have signs and symptoms that

More information

Lymphoma accounts for 10-20% of all canine cancers and is by far the most common canine blood cancer.

Lymphoma accounts for 10-20% of all canine cancers and is by far the most common canine blood cancer. Lymphoma What is cancer? Cancer is the uncontrolled growth of a small population of abnormal cells. These abnormal cells form by a mutation during the normal division cycle and are able to escape detection

More information

NON HODGKINS LYMPHOMA: AGGRESSIVE Updated June 2015 by Dr. Manna (PGY-5 Medical Oncology Resident, University of Calgary)

NON HODGKINS LYMPHOMA: AGGRESSIVE Updated June 2015 by Dr. Manna (PGY-5 Medical Oncology Resident, University of Calgary) NON HODGKINS LYMPHOMA: AGGRESSIVE Updated June 2015 by Dr. Manna (PGY-5 Medical Oncology Resident, University of Calgary) Reviewed by Dr. Michelle Geddes (Staff Hematologist, University of Calgary) and

More information